Parsec Financial Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $939K | Sell |
7,265
-72
| -1% | -$9.04K | 0.04% | 163 |
|
|
2022
Q4 | $935K | Hold |
7,337
| – | – | 0.04% | 165 |
|
|
2022
Q3 | $767K | Sell |
7,337
-248
| -3% | -$27.2K | 0.04% | 171 |
|
|
2022
Q2 | $797K | Buy |
7,585
+123
| +2% | +$14.6K | 0.04% | 175 |
|
|
2022
Q1 | $954K | Sell |
7,462
-1,467
| -16% | -$177K | 0.04% | 177 |
|
|
2021
Q4 | $1.1M | Buy |
8,929
+223
| +3% | +$29.2K | 0.05% | 161 |
|
|
2021
Q3 | $1.14M | Sell |
8,706
-92
| -1% | -$13.5K | 0.05% | 155 |
|
|
2021
Q2 | $1.37M | Buy |
8,798
+172
| +2% | +$27.9K | 0.06% | 138 |
|
|
2021
Q1 | $1.34M | Sell |
8,626
-458
| -5% | -$70.9K | 0.07% | 135 |
|
|
2020
Q4 | $1.36M | Hold |
9,084
| – | – | 0.07% | 131 |
|
|
2020
Q3 | $1.2M | Sell |
9,084
-321
| -3% | -$41.9K | 0.07% | 129 |
|
|
2020
Q2 | $1.09M | Sell |
9,405
-242
| -3% | -$27.9K | 0.07% | 129 |
|
|
2020
Q1 | $947K | Sell |
9,647
-993
| -9% | -$130K | 0.07% | 128 |
|
|
2019
Q4 | $1.55M | Sell |
10,640
-1,252
| -11% | -$173K | 0.09% | 121 |
|
|
2019
Q3 | $1.58M | Sell |
11,892
-324
| -3% | -$41.9K | 0.1% | 120 |
|
|
2019
Q2 | $1.4M | Sell |
12,216
-37,842
| -76% | -$4.43M | 0.09% | 125 |
|
|
2019
Q1 | $6.21M | Sell |
50,058
-1,144
| -2% | -$130K | 0.39% | 69 |
|
|
2018
Q4 | $5.16M | Sell |
51,202
-5,218
| -9% | -$587K | 0.37% | 70 |
|
|
2018
Q3 | $7.2M | Sell |
56,420
-1,085
| -2% | -$129K | 0.46% | 65 |
|
|
2018
Q2 | $6.22M | Sell |
57,505
-2,785
| -5% | -$303K | 0.42% | 70 |
|
|
2018
Q1 | $6.38M | Buy |
60,290
+1,954
| +3% | +$227K | 0.44% | 69 |
|
|
2017
Q4 | $6.83M | Buy |
58,336
+234
| +0.4% | +$26.5K | 0.46% | 63 |
|
|
2017
Q3 | $6.61M | Buy |
58,102
+4,421
| +8% | +$510K | 0.48% | 65 |
|
|
2017
Q2 | $6.69M | Buy |
53,681
+1,981
| +4% | +$235K | 0.53% | 61 |
|
|
2017
Q1 | $6.13M | Buy |
51,700
+17,207
| +50% | +$1.95M | 0.51% | 63 |
|
|
2016
Q4 | $3.46M | Buy |
34,493
+8,378
| +32% | +$898K | 0.3% | 88 |
|
|
2016
Q3 | $3.3M | Buy |
26,115
+2,393
| +10% | +$296K | 0.3% | 86 |
|
|
2016
Q2 | $2.77M | Buy |
23,722
+1,076
| +5% | +$122K | 0.27% | 92 |
|
|
2016
Q1 | $2.34M | Buy |
22,646
+582
| +3% | +$56.3K | 0.23% | 98 |
|
|
2015
Q4 | $2.2M | Sell |
22,064
-181
| -0.8% | -$17.7K | 0.23% | 103 |
|
|
2015
Q3 | $2.03M | Sell |
22,245
-5
| -0% | -$501 | 0.22% | 100 |
|
|
2015
Q2 | $2.36M | Sell |
22,250
-4,385
| -16% | -$485K | 0.24% | 90 |
|
|
2015
Q1 | $3.04M | Sell |
26,635
-5,354
| -17% | -$611K | 0.31% | 82 |
|
|
2014
Q4 | $3.52M | Sell |
31,989
-466
| -1% | -$49.1K | 0.37% | 76 |
|
|
2014
Q3 | $3.17M | Sell |
32,455
-4,053
| -11% | -$399K | 0.35% | 76 |
|
|
2014
Q2 | $3.68M | Sell |
36,508
-4,448
| -11% | -$434K | 0.4% | 71 |
|
|
2014
Q1 | $3.76M | Sell |
40,956
-3,018
| -7% | -$278K | 0.43% | 71 |
|
|
2013
Q4 | $3.98M | Sell |
43,974
-4,564
| -9% | -$395K | 0.47% | 71 |
|
|
2013
Q3 | $3.87M | Sell |
48,538
-2,462
| -5% | -$194K | 0.5% | 66 |
|
|
2013
Q2 | $3.71M | Buy |
+51,000
| New | +$3.81M | 0.5% | 67 |
|
Other funds holding ZBH
Parsec Financial Management's ZBH Position: Q1 2023 in Review
Parsec Financial Management reduced its Zimmer Biomet (ZBH) stake by 0.98% in Q1 2023, selling an estimated $9.04K and leaving 7,265 shares worth $939K. The position accounts for 0.04% of the portfolio, ranked #163.
Parsec Financial Management first reported a position in ZBH in Q2 2013 and has held it in 40 quarters since. The position peaked at $7.2M in Q3 2018. 993 funds tracked by Wall St. Rank hold ZBH as of Q1 2023.
- Parsec Financial Management held 7,265 shares of Zimmer Biomet worth $939K as of Q1 2023.
- Parsec Financial Management sold 72 Zimmer Biomet shares in Q1 2023, an estimated $9.04K.
- Zimmer Biomet made up 0.04% of Parsec Financial Management's portfolio in Q1 2023, its #163 holding.
- Parsec Financial Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 40 quarters since.
- Parsec Financial Management's Zimmer Biomet position peaked at $7.2M in Q3 2018.
- 993 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2023.
Based on Parsec Financial Management's 13F filing for Q1 2023, filed 6 Apr 2023.